JP6071875B2 - 毛包新生 - Google Patents

Info

Publication number

JP6071875B2

JP6071875B2 JP2013515559A JP2013515559A JP6071875B2 JP 6071875 B2 JP6071875 B2 JP 6071875B2 JP 2013515559 A JP2013515559 A JP 2013515559A JP 2013515559 A JP2013515559 A JP 2013515559A JP 6071875 B2 JP6071875 B2 JP 6071875B2

Authority

JP

Japan

Prior art keywords

cells

skin

hair

tsc2

skin substitute

Prior art date

2010-06-18

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• Discuss

• 210000003780 hair follicle Anatomy 0.000 title claims description 179
• 210000004027 cell Anatomy 0.000 claims description 500
• 210000003491 skin Anatomy 0.000 claims description 328
• 210000002950 fibroblast Anatomy 0.000 claims description 117
• 208000026911 Tuberous sclerosis complex Diseases 0.000 claims description 100
• 210000004209 hair Anatomy 0.000 claims description 97
• 230000002500 effect on skin Effects 0.000 claims description 75
• 210000002510 keratinocyte Anatomy 0.000 claims description 69
• 239000002609 medium Substances 0.000 claims description 65
• 206010028980 Neoplasm Diseases 0.000 claims description 60
• 210000002919 epithelial cell Anatomy 0.000 claims description 60
• 239000000203 mixture Substances 0.000 claims description 59
• 239000011159 matrix material Substances 0.000 claims description 54
• 210000003953 foreskin Anatomy 0.000 claims description 47
• 239000004055 small Interfering RNA Substances 0.000 claims description 38
• 108091027967 Small hairpin RNA Proteins 0.000 claims description 37
• 238000002054 transplantation Methods 0.000 claims description 34
• 102100027909 Folliculin Human genes 0.000 claims description 24
• 101001060703 Homo sapiens Folliculin Proteins 0.000 claims description 24
• 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 claims description 24
• 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 claims description 24
• 239000004005 microsphere Substances 0.000 claims description 22
• 210000001732 sebaceous gland Anatomy 0.000 claims description 22
• 210000001061 forehead Anatomy 0.000 claims description 20
• 206010016629 fibroma Diseases 0.000 claims description 19
• 230000001939 inductive effect Effects 0.000 claims description 18
• 230000003325 follicular Effects 0.000 claims description 16
• 201000004384 Alopecia Diseases 0.000 claims description 14
• 230000036961 partial effect Effects 0.000 claims description 13
• 108010022452 Collagen Type I Proteins 0.000 claims description 12
• 102000012422 Collagen Type I Human genes 0.000 claims description 12
• 206010027145 Melanocytic naevus Diseases 0.000 claims description 12
• 208000007256 Nevus Diseases 0.000 claims description 12
• 230000007547 defect Effects 0.000 claims description 12
• 208000003200 Adenoma Diseases 0.000 claims description 11
• 208000003019 Neurofibromatosis 1 Diseases 0.000 claims description 11
• 230000001105 regulatory effect Effects 0.000 claims description 11
• 231100000241 scar Toxicity 0.000 claims description 11
• 208000011580 syndromic disease Diseases 0.000 claims description 11
• 208000024963 hair loss Diseases 0.000 claims description 10
• 230000003676 hair loss Effects 0.000 claims description 10
• 210000002107 sheath cell Anatomy 0.000 claims description 10
• 210000004243 sweat Anatomy 0.000 claims description 10
• 102000008186 Collagen Human genes 0.000 claims description 9
• 108010035532 Collagen Proteins 0.000 claims description 9
• 102000014160 PTEN Phosphohydrolase Human genes 0.000 claims description 9
• 108010011536 PTEN Phosphohydrolase Proteins 0.000 claims description 9
• 108091030071 RNAI Proteins 0.000 claims description 9
• 229920001436 collagen Polymers 0.000 claims description 9
• 230000009368 gene silencing by RNA Effects 0.000 claims description 9
• 206010001233 Adenoma benign Diseases 0.000 claims description 8
• 208000012609 Cowden disease Diseases 0.000 claims description 8
• 201000002847 Cowden syndrome Diseases 0.000 claims description 8
• 102000001267 GSK3 Human genes 0.000 claims description 8
• 108060006662 GSK3 Proteins 0.000 claims description 8
• 208000008770 Multiple Hamartoma Syndrome Diseases 0.000 claims description 8
• NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 claims description 8
• 210000000056 organ Anatomy 0.000 claims description 8
• 239000012679 serum free medium Substances 0.000 claims description 8
• 101000582631 Homo sapiens Menin Proteins 0.000 claims description 7
• 102000011782 Keratins Human genes 0.000 claims description 7
• 108010076876 Keratins Proteins 0.000 claims description 7
• 102100030550 Menin Human genes 0.000 claims description 6
• 108091007960 PI3Ks Proteins 0.000 claims description 6
• 102000046951 Ras Homolog Enriched in Brain Human genes 0.000 claims description 6
• 108020004459 Small interfering RNA Proteins 0.000 claims description 6
• 210000000804 eccrine gland Anatomy 0.000 claims description 6
• 201000009030 Carcinoma Diseases 0.000 claims description 5
• 108010086291 Deubiquitinating Enzyme CYLD Proteins 0.000 claims description 5
• 102100022466 Eukaryotic translation initiation factor 4E-binding protein 1 Human genes 0.000 claims description 5
• 108050000946 Eukaryotic translation initiation factor 4E-binding protein 1 Proteins 0.000 claims description 5
• 101000690268 Homo sapiens Proline-rich AKT1 substrate 1 Proteins 0.000 claims description 5
• 101100388114 Mus musculus Deptor gene Proteins 0.000 claims description 5
• 102100024091 Proline-rich AKT1 substrate 1 Human genes 0.000 claims description 5
• 101150020518 RHEB gene Proteins 0.000 claims description 5
• 108700019578 Ras Homolog Enriched in Brain Proteins 0.000 claims description 5
• 208000010932 epithelial neoplasm Diseases 0.000 claims description 5
• 208000009999 tuberous sclerosis Diseases 0.000 claims description 5
• 101150107888 AKT2 gene Proteins 0.000 claims description 4
• 101150051155 Akt3 gene Proteins 0.000 claims description 4
• 102000046985 LST8 Homolog mTOR Associated Human genes 0.000 claims description 4
• 101100087591 Mus musculus Rictor gene Proteins 0.000 claims description 4
• 102100024184 Polymerase delta-interacting protein 3 Human genes 0.000 claims description 4
• 101710142722 Polymerase delta-interacting protein 3 Proteins 0.000 claims description 4
• 101150071831 RPS6KA1 gene Proteins 0.000 claims description 4
• 108010029031 Regulatory-Associated Protein of mTOR Proteins 0.000 claims description 4
• 102100040969 Regulatory-associated protein of mTOR Human genes 0.000 claims description 4
• 102000002278 Ribosomal Proteins Human genes 0.000 claims description 4
• 108010000605 Ribosomal Proteins Proteins 0.000 claims description 4
• 108010074436 Sterol Regulatory Element Binding Protein 1 Proteins 0.000 claims description 4
• 101710115678 Target of rapamycin complex subunit LST8 Proteins 0.000 claims description 4
• 101150045355 akt1 gene Proteins 0.000 claims description 4
• 210000005260 human cell Anatomy 0.000 claims description 4
• 230000002757 inflammatory effect Effects 0.000 claims description 4
• 208000007538 neurilemmoma Diseases 0.000 claims description 4
• 230000009467 reduction Effects 0.000 claims description 4
• 201000007651 Brooke-Spiegler syndrome Diseases 0.000 claims description 3
• 208000009905 Neurofibromatoses Diseases 0.000 claims description 3
• 230000002776 aggregation Effects 0.000 claims description 3
• 230000002124 endocrine Effects 0.000 claims description 3
• 238000009472 formulation Methods 0.000 claims description 3
• 201000004931 neurofibromatosis Diseases 0.000 claims description 3
• 206010039667 schwannoma Diseases 0.000 claims description 3
• 102000007530 Neurofibromin 1 Human genes 0.000 claims description 2
• 108010085793 Neurofibromin 1 Proteins 0.000 claims description 2
• 238000005054 agglomeration Methods 0.000 claims description 2
• 201000004260 follicular adenoma Diseases 0.000 claims description 2
• 208000030878 follicular thyroid adenoma Diseases 0.000 claims description 2
• 239000007972 injectable composition Substances 0.000 claims description 2
• 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 claims 1
• 102000007443 Deubiquitinating Enzyme CYLD Human genes 0.000 claims 1
• 102100024908 Ribosomal protein S6 kinase beta-1 Human genes 0.000 claims 1
• 101710108924 Ribosomal protein S6 kinase beta-1 Proteins 0.000 claims 1
• 102000008078 Sterol Regulatory Element Binding Protein 1 Human genes 0.000 claims 1
• 101000795659 Homo sapiens Tuberin Proteins 0.000 description 254
• 102100031638 Tuberin Human genes 0.000 description 249
• 230000006870 function Effects 0.000 description 140
• 108090000623 proteins and genes Proteins 0.000 description 137
• 102100031561 Hamartin Human genes 0.000 description 119
• 101000795643 Homo sapiens Hamartin Proteins 0.000 description 118
• 238000000034 method Methods 0.000 description 85
• 210000001519 tissue Anatomy 0.000 description 76
• 241000699670 Mus sp. Species 0.000 description 70
• 102000004169 proteins and genes Human genes 0.000 description 64
• 208000027418 Wounds and injury Diseases 0.000 description 52
• 206010052428 Wound Diseases 0.000 description 50
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 49
• 229960002930 sirolimus Drugs 0.000 description 49
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 49
• 102000008135 Mechanistic Target of Rapamycin Complex 1 Human genes 0.000 description 48
• 108010035196 Mechanistic Target of Rapamycin Complex 1 Proteins 0.000 description 48
• 238000003197 gene knockdown Methods 0.000 description 47
• 230000002829 reductive effect Effects 0.000 description 43
• 230000014509 gene expression Effects 0.000 description 40
• 208000002927 Hamartoma Diseases 0.000 description 39
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 38
• 210000002615 epidermis Anatomy 0.000 description 38
• 239000010410 layer Substances 0.000 description 35
• 230000011664 signaling Effects 0.000 description 35
• 230000001965 increasing effect Effects 0.000 description 34
• 210000004287 null lymphocyte Anatomy 0.000 description 34
• 239000013598 vector Substances 0.000 description 31
• 210000004207 dermis Anatomy 0.000 description 30
• 230000000694 effects Effects 0.000 description 30
• 238000002347 injection Methods 0.000 description 30
• 239000007924 injection Substances 0.000 description 30
• 108020004414 DNA Proteins 0.000 description 27
• 210000001339 epidermal cell Anatomy 0.000 description 23
• 210000000130 stem cell Anatomy 0.000 description 23
• 102000009308 Mechanistic Target of Rapamycin Complex 2 Human genes 0.000 description 22
• 108010034057 Mechanistic Target of Rapamycin Complex 2 Proteins 0.000 description 22
• 241000699666 Mus <mouse, genus> Species 0.000 description 21
• 239000000523 sample Substances 0.000 description 21
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
• 238000004458 analytical method Methods 0.000 description 20
• 230000015572 biosynthetic process Effects 0.000 description 20
• 230000035772 mutation Effects 0.000 description 20
• 230000037311 normal skin Effects 0.000 description 20
• 238000010186 staining Methods 0.000 description 19
• 210000004919 hair shaft Anatomy 0.000 description 17
• 239000003981 vehicle Substances 0.000 description 17
• 230000000762 glandular Effects 0.000 description 16
• 210000002768 hair cell Anatomy 0.000 description 16
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 16
• 238000011282 treatment Methods 0.000 description 16
• 108091026890 Coding region Proteins 0.000 description 15
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
• 210000000981 epithelium Anatomy 0.000 description 15
• 230000002401 inhibitory effect Effects 0.000 description 15
• 230000009707 neogenesis Effects 0.000 description 15
• 239000000047 product Substances 0.000 description 15
• 210000004918 root sheath Anatomy 0.000 description 15
• 239000000243 solution Substances 0.000 description 15
• 102000013814 Wnt Human genes 0.000 description 14
• 108050003627 Wnt Proteins 0.000 description 14
• 230000012010 growth Effects 0.000 description 14
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 13
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 13
• 206010029098 Neoplasm skin Diseases 0.000 description 13
• -1 S6K1 Proteins 0.000 description 13
• 208000000453 Skin Neoplasms Diseases 0.000 description 13
• 238000004113 cell culture Methods 0.000 description 13
• 238000003364 immunohistochemistry Methods 0.000 description 13
• 238000000338 in vitro Methods 0.000 description 13
• 239000007788 liquid Substances 0.000 description 13
• 230000003278 mimic effect Effects 0.000 description 13
• 210000004877 mucosa Anatomy 0.000 description 13
• 210000004927 skin cell Anatomy 0.000 description 13
• 239000011780 sodium chloride Substances 0.000 description 13
• 238000009396 hybridization Methods 0.000 description 12
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
• 230000004936 stimulating effect Effects 0.000 description 12
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
• 210000004204 blood vessel Anatomy 0.000 description 11
• 230000006378 damage Effects 0.000 description 11
• 230000007423 decrease Effects 0.000 description 11
• 239000002773 nucleotide Substances 0.000 description 11
• 125000003729 nucleotide group Chemical group 0.000 description 11
• 239000008188 pellet Substances 0.000 description 11
• 239000002953 phosphate buffered saline Substances 0.000 description 11
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
• 102100033714 40S ribosomal protein S6 Human genes 0.000 description 10
• 108010011376 AMP-Activated Protein Kinases Proteins 0.000 description 10
• 102000014156 AMP-Activated Protein Kinases Human genes 0.000 description 10
• 208000024834 Neurofibromatosis type 1 Diseases 0.000 description 10
• 241000700159 Rattus Species 0.000 description 10
• 108090000221 Ribosomal protein S6 Proteins 0.000 description 10
• 239000003636 conditioned culture medium Substances 0.000 description 10
• 238000001804 debridement Methods 0.000 description 10
• 230000003779 hair growth Effects 0.000 description 10
• 239000012528 membrane Substances 0.000 description 10
• 108020004999 messenger RNA Proteins 0.000 description 10
• 239000002245 particle Substances 0.000 description 10
• 229920003023 plastic Polymers 0.000 description 10
• 239000004033 plastic Substances 0.000 description 10
• 210000004761 scalp Anatomy 0.000 description 10
• 238000001890 transfection Methods 0.000 description 10
• 238000001262 western blot Methods 0.000 description 10
• 239000004698 Polyethylene Substances 0.000 description 9
• 238000013459 approach Methods 0.000 description 9
• 238000003556 assay Methods 0.000 description 9
• 238000002513 implantation Methods 0.000 description 9
• 230000006698 induction Effects 0.000 description 9
• 210000004940 nucleus Anatomy 0.000 description 9
• 239000013612 plasmid Substances 0.000 description 9
• 238000002360 preparation method Methods 0.000 description 9
• 239000000758 substrate Substances 0.000 description 9
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
• 230000004913 activation Effects 0.000 description 8
• 239000000872 buffer Substances 0.000 description 8
• 230000004069 differentiation Effects 0.000 description 8
• 235000021186 dishes Nutrition 0.000 description 8
• 230000003828 downregulation Effects 0.000 description 8
• 210000004907 gland Anatomy 0.000 description 8
• 239000001963 growth medium Substances 0.000 description 8
• 210000004379 membrane Anatomy 0.000 description 8
• 150000007523 nucleic acids Chemical class 0.000 description 8
• 230000035755 proliferation Effects 0.000 description 8
• 229950010131 puromycin Drugs 0.000 description 8
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 8
• 239000000126 substance Substances 0.000 description 8
• 238000012360 testing method Methods 0.000 description 8
• 210000004881 tumor cell Anatomy 0.000 description 8
• 241000283690 Bos taurus Species 0.000 description 7
• 229920001661 Chitosan Polymers 0.000 description 7
• 108091034117 Oligonucleotide Proteins 0.000 description 7
• 108010017070 Zinc Finger Nucleases Proteins 0.000 description 7
• 239000000853 adhesive Substances 0.000 description 7
• 230000000735 allogeneic effect Effects 0.000 description 7
• 230000003698 anagen phase Effects 0.000 description 7
• 239000000074 antisense oligonucleotide Substances 0.000 description 7
• 238000012230 antisense oligonucleotides Methods 0.000 description 7
• 230000003247 decreasing effect Effects 0.000 description 7
• 239000012634 fragment Substances 0.000 description 7
• 239000003102 growth factor Substances 0.000 description 7
• 210000001208 inner root sheath cell Anatomy 0.000 description 7
• 238000002955 isolation Methods 0.000 description 7
• 238000012163 sequencing technique Methods 0.000 description 7
• 238000013518 transcription Methods 0.000 description 7
• 230000035897 transcription Effects 0.000 description 7
• 238000010361 transduction Methods 0.000 description 7
• 230000026683 transduction Effects 0.000 description 7
• 238000012546 transfer Methods 0.000 description 7
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
• 208000032544 Cicatrix Diseases 0.000 description 6
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 6
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 6
• 102000004877 Insulin Human genes 0.000 description 6
• 108090001061 Insulin Proteins 0.000 description 6
• 108091092195 Intron Proteins 0.000 description 6
• 108091008611 Protein Kinase B Proteins 0.000 description 6
• 102100026715 Serine/threonine-protein kinase STK11 Human genes 0.000 description 6
• 101710181599 Serine/threonine-protein kinase STK11 Proteins 0.000 description 6
• 230000001070 adhesive effect Effects 0.000 description 6
• 208000013748 benign neoplasm of appendix Diseases 0.000 description 6
• 210000001185 bone marrow Anatomy 0.000 description 6
• 230000004663 cell proliferation Effects 0.000 description 6
• 239000003153 chemical reaction reagent Substances 0.000 description 6
• 210000000349 chromosome Anatomy 0.000 description 6
• 238000003776 cleavage reaction Methods 0.000 description 6
• 238000010494 dissociation reaction Methods 0.000 description 6
• 230000005593 dissociations Effects 0.000 description 6
• 210000002889 endothelial cell Anatomy 0.000 description 6
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 6
• 210000000416 exudates and transudate Anatomy 0.000 description 6
• JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
• 238000001727 in vivo Methods 0.000 description 6
• 229940125396 insulin Drugs 0.000 description 6
• 239000003550 marker Substances 0.000 description 6
• 210000002901 mesenchymal stem cell Anatomy 0.000 description 6
• 230000004048 modification Effects 0.000 description 6
• 238000012986 modification Methods 0.000 description 6
• 102000039446 nucleic acids Human genes 0.000 description 6
• 108020004707 nucleic acids Proteins 0.000 description 6
• 230000008569 process Effects 0.000 description 6
• 230000001737 promoting effect Effects 0.000 description 6
• 238000012552 review Methods 0.000 description 6
• 230000037387 scars Effects 0.000 description 6
• 230000007017 scission Effects 0.000 description 6
• 239000006228 supernatant Substances 0.000 description 6
• 239000000725 suspension Substances 0.000 description 6
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 6
• 238000005406 washing Methods 0.000 description 6
• JUJOJJFIOBKCID-MRXNPFEDSA-N (3r)-3-[(3,4-dihydroxyphenyl)methyl]-3,7,8-trihydroxy-2h-chromen-4-one Chemical compound C1=C(O)C(O)=CC=C1C[C@]1(O)C(=O)C2=CC=C(O)C(O)=C2OC1 JUJOJJFIOBKCID-MRXNPFEDSA-N 0.000 description 5
• 102400001368 Epidermal growth factor Human genes 0.000 description 5
• 101800003838 Epidermal growth factor Proteins 0.000 description 5
• 229920000209 Hexadimethrine bromide Polymers 0.000 description 5
• 241001465754 Metazoa Species 0.000 description 5
• 102000038030 PI3Ks Human genes 0.000 description 5
• 206010034764 Peutz-Jeghers syndrome Diseases 0.000 description 5
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 5
• 208000025865 Ulcer Diseases 0.000 description 5
• 238000007792 addition Methods 0.000 description 5
• 230000001464 adherent effect Effects 0.000 description 5
• 229910002091 carbon monoxide Inorganic materials 0.000 description 5
• 230000001413 cellular effect Effects 0.000 description 5
• 230000008859 change Effects 0.000 description 5
• 230000000295 complement effect Effects 0.000 description 5
• 239000002131 composite material Substances 0.000 description 5
• 208000031513 cyst Diseases 0.000 description 5
• 230000007812 deficiency Effects 0.000 description 5
• 238000012217 deletion Methods 0.000 description 5
• 230000037430 deletion Effects 0.000 description 5
• 230000029087 digestion Effects 0.000 description 5
• 210000003317 double-positive, alpha-beta immature T lymphocyte Anatomy 0.000 description 5
• 239000003814 drug Substances 0.000 description 5
• 229940116977 epidermal growth factor Drugs 0.000 description 5
• 230000003176 fibrotic effect Effects 0.000 description 5
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 5
• 230000005764 inhibitory process Effects 0.000 description 5
• 230000007774 longterm Effects 0.000 description 5
• 239000000463 material Substances 0.000 description 5
• 210000002864 mononuclear phagocyte Anatomy 0.000 description 5
• JTSLALYXYSRPGW-UHFFFAOYSA-N n-[5-(4-cyanophenyl)-1h-pyrrolo[2,3-b]pyridin-3-yl]pyridine-3-carboxamide Chemical compound C=1C=CN=CC=1C(=O)NC(C1=C2)=CNC1=NC=C2C1=CC=C(C#N)C=C1 JTSLALYXYSRPGW-UHFFFAOYSA-N 0.000 description 5
• 230000001338 necrotic effect Effects 0.000 description 5
• 210000005036 nerve Anatomy 0.000 description 5
• 239000012188 paraffin wax Substances 0.000 description 5
• 230000037361 pathway Effects 0.000 description 5
• 229920000573 polyethylene Polymers 0.000 description 5
• 102000040430 polynucleotide Human genes 0.000 description 5
• 108091033319 polynucleotide Proteins 0.000 description 5
• 239000002157 polynucleotide Substances 0.000 description 5
• 229920001184 polypeptide Polymers 0.000 description 5
• 108090000765 processed proteins & peptides Proteins 0.000 description 5
• 102000004196 processed proteins & peptides Human genes 0.000 description 5
• 230000004853 protein function Effects 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 238000001356 surgical procedure Methods 0.000 description 5
• 210000000106 sweat gland Anatomy 0.000 description 5
• 231100000397 ulcer Toxicity 0.000 description 5
• 230000029663 wound healing Effects 0.000 description 5
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
• 229920000936 Agarose Polymers 0.000 description 4
• 206010002091 Anaesthesia Diseases 0.000 description 4
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
• 208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 description 4
• 108060005980 Collagenase Proteins 0.000 description 4
• 102000029816 Collagenase Human genes 0.000 description 4
• 101100508533 Drosophila melanogaster IKKbeta gene Proteins 0.000 description 4
• 108010067306 Fibronectins Proteins 0.000 description 4
• 102000016359 Fibronectins Human genes 0.000 description 4
• 101000934372 Homo sapiens Macrosialin Proteins 0.000 description 4
• 102100025136 Macrosialin Human genes 0.000 description 4
• 108700011259 MicroRNAs Proteins 0.000 description 4
• 102000008730 Nestin Human genes 0.000 description 4
• 108010088225 Nestin Proteins 0.000 description 4
• 229930182555 Penicillin Natural products 0.000 description 4
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
• 102100024250 Ubiquitin carboxyl-terminal hydrolase CYLD Human genes 0.000 description 4
• 230000037005 anaesthesia Effects 0.000 description 4
• 230000000844 anti-bacterial effect Effects 0.000 description 4
• 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 description 4
• 230000001580 bacterial effect Effects 0.000 description 4
• 230000000740 bleeding effect Effects 0.000 description 4
• 230000012292 cell migration Effects 0.000 description 4
• 239000006285 cell suspension Substances 0.000 description 4
• 230000005754 cellular signaling Effects 0.000 description 4
• 229960002424 collagenase Drugs 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 4
• 150000001875 compounds Chemical class 0.000 description 4
• 230000001054 cortical effect Effects 0.000 description 4
• 238000012258 culturing Methods 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
• 108010007093 dispase Proteins 0.000 description 4
• 230000005782 double-strand break Effects 0.000 description 4
• 230000002222 downregulating effect Effects 0.000 description 4
• 229940079593 drug Drugs 0.000 description 4
• 239000003623 enhancer Substances 0.000 description 4
• 210000002514 epidermal stem cell Anatomy 0.000 description 4
• 239000000835 fiber Substances 0.000 description 4
• 239000000499 gel Substances 0.000 description 4
• 230000030279 gene silencing Effects 0.000 description 4
• 230000035876 healing Effects 0.000 description 4
• 229920002674 hyaluronan Polymers 0.000 description 4
• 230000002055 immunohistochemical effect Effects 0.000 description 4
• 238000007901 in situ hybridization Methods 0.000 description 4
• 239000003112 inhibitor Substances 0.000 description 4
• 238000003780 insertion Methods 0.000 description 4
• 230000037431 insertion Effects 0.000 description 4
• 230000002452 interceptive effect Effects 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• 230000033001 locomotion Effects 0.000 description 4
• 108010082117 matrigel Proteins 0.000 description 4
• 239000002679 microRNA Substances 0.000 description 4
• 230000005012 migration Effects 0.000 description 4
• 238000013508 migration Methods 0.000 description 4
• 238000004264 monolayer culture Methods 0.000 description 4
• 210000005055 nestin Anatomy 0.000 description 4
• 231100000065 noncytotoxic Toxicity 0.000 description 4
• 230000002020 noncytotoxic effect Effects 0.000 description 4
• 229940049954 penicillin Drugs 0.000 description 4
• 230000026731 phosphorylation Effects 0.000 description 4
• 238000006366 phosphorylation reaction Methods 0.000 description 4
• 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 4
• 239000002243 precursor Substances 0.000 description 4
• 230000002062 proliferating effect Effects 0.000 description 4
• 230000002441 reversible effect Effects 0.000 description 4
• 210000002966 serum Anatomy 0.000 description 4
• 238000010561 standard procedure Methods 0.000 description 4
• 229960005322 streptomycin Drugs 0.000 description 4
• WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 description 4
• 208000024891 symptom Diseases 0.000 description 4
• 230000008685 targeting Effects 0.000 description 4
• 230000003827 upregulation Effects 0.000 description 4
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 3
• 102000015735 Beta-catenin Human genes 0.000 description 3
• 108060000903 Beta-catenin Proteins 0.000 description 3
• 206010010356 Congenital anomaly Diseases 0.000 description 3
• 229920000742 Cotton Polymers 0.000 description 3
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 3
• 108010022355 Fibroins Proteins 0.000 description 3
• 206010019043 Hair follicle tumour benign Diseases 0.000 description 3
• 101710175981 Hamartin Proteins 0.000 description 3
• 239000012981 Hank's balanced salt solution Substances 0.000 description 3
• 241000282412 Homo Species 0.000 description 3
• 101710156785 Insulin-like receptor Proteins 0.000 description 3
• PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 3
• 206010062575 Muscle contracture Diseases 0.000 description 3
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
• 201000004404 Neurofibroma Diseases 0.000 description 3
• 108091028043 Nucleic acid sequence Proteins 0.000 description 3
• 239000004677 Nylon Substances 0.000 description 3
• 102100036143 Polycystin-1 Human genes 0.000 description 3
• 101710146367 Polycystin-1 Proteins 0.000 description 3
• 208000007531 Proteus syndrome Diseases 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• 102100026839 Sterol regulatory element-binding protein 1 Human genes 0.000 description 3
• 101710188371 Sulfate-binding protein Proteins 0.000 description 3
• 102000004142 Trypsin Human genes 0.000 description 3
• 108090000631 Trypsin Proteins 0.000 description 3
• 102000002027 Tuberin Human genes 0.000 description 3
• 108050009309 Tuberin Proteins 0.000 description 3
• 102000044632 Tuberous Sclerosis Complex 1 Human genes 0.000 description 3
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 3
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 3
• 102100035071 Vimentin Human genes 0.000 description 3
• 108010065472 Vimentin Proteins 0.000 description 3
• 230000005856 abnormality Effects 0.000 description 3
• 239000000654 additive Substances 0.000 description 3
• 235000010443 alginic acid Nutrition 0.000 description 3
• 229920000615 alginic acid Polymers 0.000 description 3
• 208000004631 alopecia areata Diseases 0.000 description 3
• 230000033115 angiogenesis Effects 0.000 description 3
• 239000003242 anti bacterial agent Substances 0.000 description 3
• 229940088710 antibiotic agent Drugs 0.000 description 3
• 239000000427 antigen Substances 0.000 description 3
• 108091007433 antigens Proteins 0.000 description 3
• 102000036639 antigens Human genes 0.000 description 3
• 210000002469 basement membrane Anatomy 0.000 description 3
• 239000011324 bead Substances 0.000 description 3
• 230000010261 cell growth Effects 0.000 description 3
• 239000013592 cell lysate Substances 0.000 description 3
• 239000002771 cell marker Substances 0.000 description 3
• 210000003855 cell nucleus Anatomy 0.000 description 3
• 239000003795 chemical substances by application Substances 0.000 description 3
• 210000002808 connective tissue Anatomy 0.000 description 3
• 208000006111 contracture Diseases 0.000 description 3
• 238000012937 correction Methods 0.000 description 3
• 238000010586 diagram Methods 0.000 description 3
• 230000002255 enzymatic effect Effects 0.000 description 3
• 238000001976 enzyme digestion Methods 0.000 description 3
• 238000011156 evaluation Methods 0.000 description 3
• 239000000284 extract Substances 0.000 description 3
• 239000012737 fresh medium Substances 0.000 description 3
• 238000012226 gene silencing method Methods 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 230000031774 hair cycle Effects 0.000 description 3
• 210000000442 hair follicle cell Anatomy 0.000 description 3
• 230000003781 hair follicle cycle Effects 0.000 description 3
• 230000023643 hair follicle morphogenesis Effects 0.000 description 3
• 230000003661 hair follicle regeneration Effects 0.000 description 3
• 229960000890 hydrocortisone Drugs 0.000 description 3
• 238000007654 immersion Methods 0.000 description 3
• 239000007943 implant Substances 0.000 description 3
• 210000004263 induced pluripotent stem cell Anatomy 0.000 description 3
• 238000001802 infusion Methods 0.000 description 3
• 208000014674 injury Diseases 0.000 description 3
• 229960002725 isoflurane Drugs 0.000 description 3
• 210000003734 kidney Anatomy 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 230000004807 localization Effects 0.000 description 3
• 238000004519 manufacturing process Methods 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 229920000609 methyl cellulose Polymers 0.000 description 3
• 239000001923 methylcellulose Substances 0.000 description 3
• 239000002121 nanofiber Substances 0.000 description 3
• 210000001982 neural crest cell Anatomy 0.000 description 3
• 208000029974 neurofibrosarcoma Diseases 0.000 description 3
• 229920001778 nylon Polymers 0.000 description 3
• 230000008488 polyadenylation Effects 0.000 description 3
• 238000011069 regeneration method Methods 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 230000003248 secreting effect Effects 0.000 description 3
• 230000028327 secretion Effects 0.000 description 3
• 230000037380 skin damage Effects 0.000 description 3
• 210000004085 squamous epithelial cell Anatomy 0.000 description 3
• 230000008093 supporting effect Effects 0.000 description 3
• 230000001225 therapeutic effect Effects 0.000 description 3
• 238000013519 translation Methods 0.000 description 3
• 239000012588 trypsin Substances 0.000 description 3
• SZCZSKMCTGEJKI-UHFFFAOYSA-N tuberin Natural products COC1=CC=C(C=CNC=O)C=C1 SZCZSKMCTGEJKI-UHFFFAOYSA-N 0.000 description 3
• 238000011144 upstream manufacturing Methods 0.000 description 3
• 230000002792 vascular Effects 0.000 description 3
• 210000005048 vimentin Anatomy 0.000 description 3
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
• 108010085238 Actins Proteins 0.000 description 2
• 102000007469 Actins Human genes 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• 101150012716 CDK1 gene Proteins 0.000 description 2
• 101100290380 Caenorhabditis elegans cel-1 gene Proteins 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• 108010067316 Catenins Proteins 0.000 description 2
• 102000016362 Catenins Human genes 0.000 description 2
• 208000009043 Chemical Burns Diseases 0.000 description 2
• 108020004705 Codon Proteins 0.000 description 2
• 102000004266 Collagen Type IV Human genes 0.000 description 2
• 108010042086 Collagen Type IV Proteins 0.000 description 2
• 206010010904 Convulsion Diseases 0.000 description 2
• 108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 description 2
• 102000002664 Core Binding Factor Alpha 2 Subunit Human genes 0.000 description 2
• 206010011732 Cyst Diseases 0.000 description 2
• 201000005171 Cystadenoma Diseases 0.000 description 2
• 238000000116 DAPI staining Methods 0.000 description 2
• 101100239628 Danio rerio myca gene Proteins 0.000 description 2
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
• 102100030012 Deoxyribonuclease-1 Human genes 0.000 description 2
• 102000016942 Elastin Human genes 0.000 description 2
• 108010014258 Elastin Proteins 0.000 description 2
• 102000004190 Enzymes Human genes 0.000 description 2
• 108090000790 Enzymes Proteins 0.000 description 2
• 206010014989 Epidermolysis bullosa Diseases 0.000 description 2
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
• 108010073385 Fibrin Proteins 0.000 description 2
• 102000009123 Fibrin Human genes 0.000 description 2
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
• 102000018898 GTPase-Activating Proteins Human genes 0.000 description 2
• 108091006094 GTPase-accelerating proteins Proteins 0.000 description 2
• DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 2
• 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 2
• 101000944909 Homo sapiens Ribosomal protein S6 kinase alpha-1 Proteins 0.000 description 2
• 102100034343 Integrase Human genes 0.000 description 2
• 108010061833 Integrases Proteins 0.000 description 2
• 102100040445 Keratin, type I cytoskeletal 14 Human genes 0.000 description 2
• 102100040443 Keratin, type I cytoskeletal 15 Human genes 0.000 description 2
• 108010066330 Keratin-15 Proteins 0.000 description 2
• 239000002147 L01XE04 - Sunitinib Substances 0.000 description 2
• 108010085895 Laminin Proteins 0.000 description 2
• 102000007547 Laminin Human genes 0.000 description 2
• 241000713666 Lentivirus Species 0.000 description 2
• 101150039798 MYC gene Proteins 0.000 description 2
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
• 108010013295 Microbial collagenase Proteins 0.000 description 2
• 108091092878 Microsatellite Proteins 0.000 description 2
• 101100485095 Mus musculus Wnt10b gene Proteins 0.000 description 2
• 108020004485 Nonsense Codon Proteins 0.000 description 2
• SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 101710200437 Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial Proteins 0.000 description 2
• 108010016731 PPAR gamma Proteins 0.000 description 2
• 108091093037 Peptide nucleic acid Proteins 0.000 description 2
• 102000012132 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 2
• 108091000080 Phosphotransferase Proteins 0.000 description 2
• 229920001213 Polysorbate 20 Polymers 0.000 description 2
• 239000004372 Polyvinyl alcohol Substances 0.000 description 2
• RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
• 102000009389 Prostaglandin D receptors Human genes 0.000 description 2
• 108050000258 Prostaglandin D receptors Proteins 0.000 description 2
• 108010067787 Proteoglycans Proteins 0.000 description 2
• 102000016611 Proteoglycans Human genes 0.000 description 2
• 238000012181 QIAquick gel extraction kit Methods 0.000 description 2
• 102000014113 Rabaptin-5 Human genes 0.000 description 2
• 108050003998 Rabaptin-5 Proteins 0.000 description 2
• 102100033536 Ribosomal protein S6 kinase alpha-1 Human genes 0.000 description 2
• 241000283984 Rodentia Species 0.000 description 2
• YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
• 206010039509 Scab Diseases 0.000 description 2
• 206010048810 Sebaceous hyperplasia Diseases 0.000 description 2
• 208000028990 Skin injury Diseases 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 2
• 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 2
• 208000002847 Surgical Wound Diseases 0.000 description 2
• 210000001744 T-lymphocyte Anatomy 0.000 description 2
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
• 102000004338 Transferrin Human genes 0.000 description 2
• 108090000901 Transferrin Proteins 0.000 description 2
• 108050008367 Transmembrane emp24 domain-containing protein 7 Proteins 0.000 description 2
• 102000004243 Tubulin Human genes 0.000 description 2
• 108090000704 Tubulin Proteins 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical class O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• 101100459258 Xenopus laevis myc-a gene Proteins 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 238000002679 ablation Methods 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• 230000000996 additive effect Effects 0.000 description 2
• 210000001789 adipocyte Anatomy 0.000 description 2
• 231100000360 alopecia Toxicity 0.000 description 2
• 125000000539 amino acid group Chemical group 0.000 description 2
• 210000003484 anatomy Anatomy 0.000 description 2
• 239000002870 angiogenesis inducing agent Substances 0.000 description 2
• 230000001772 anti-angiogenic effect Effects 0.000 description 2
• 230000000692 anti-sense effect Effects 0.000 description 2
• 229940121375 antifungal agent Drugs 0.000 description 2
• 210000000040 apocrine gland Anatomy 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 239000012472 biological sample Substances 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• 235000008429 bread Nutrition 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 230000021164 cell adhesion Effects 0.000 description 2
• 210000003850 cellular structure Anatomy 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 210000002230 centromere Anatomy 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 239000012459 cleaning agent Substances 0.000 description 2
• 208000010877 cognitive disease Diseases 0.000 description 2
• 238000007906 compression Methods 0.000 description 2
• 230000006835 compression Effects 0.000 description 2
• 239000012141 concentrate Substances 0.000 description 2
• 210000001608 connective tissue cell Anatomy 0.000 description 2
• 239000012228 culture supernatant Substances 0.000 description 2
• 238000005520 cutting process Methods 0.000 description 2
• 210000001968 dental pulp cell Anatomy 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 239000003599 detergent Substances 0.000 description 2
• 201000010099 disease Diseases 0.000 description 2
• 208000035475 disorder Diseases 0.000 description 2
• 239000012153 distilled water Substances 0.000 description 2
• 239000003937 drug carrier Substances 0.000 description 2
• 229920002549 elastin Polymers 0.000 description 2
• 238000001962 electrophoresis Methods 0.000 description 2
• 238000004520 electroporation Methods 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 239000003344 environmental pollutant Substances 0.000 description 2
• 230000006862 enzymatic digestion Effects 0.000 description 2
• 229940088598 enzyme Drugs 0.000 description 2
• 238000004299 exfoliation Methods 0.000 description 2
• 210000002744 extracellular matrix Anatomy 0.000 description 2
• 238000000605 extraction Methods 0.000 description 2
• 230000001815 facial effect Effects 0.000 description 2
• 210000004700 fetal blood Anatomy 0.000 description 2
• 229950003499 fibrin Drugs 0.000 description 2
• 239000007850 fluorescent dye Substances 0.000 description 2
• 238000002509 fluorescent in situ hybridization Methods 0.000 description 2
• 230000004927 fusion Effects 0.000 description 2
• 239000007789 gas Substances 0.000 description 2
• 210000001035 gastrointestinal tract Anatomy 0.000 description 2
• 238000001415 gene therapy Methods 0.000 description 2
• 238000002695 general anesthesia Methods 0.000 description 2
• 230000009583 hair follicle growth Effects 0.000 description 2
• 230000009579 hair morphogenesis Effects 0.000 description 2
• 210000002216 heart Anatomy 0.000 description 2
• 210000001182 human Y chromosome Anatomy 0.000 description 2
• 235000003642 hunger Nutrition 0.000 description 2
• 229940099552 hyaluronan Drugs 0.000 description 2
• KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 2
• 229960003160 hyaluronic acid Drugs 0.000 description 2
• 230000006951 hyperphosphorylation Effects 0.000 description 2
• 206010020718 hyperplasia Diseases 0.000 description 2
• 238000003119 immunoblot Methods 0.000 description 2
• 238000010166 immunofluorescence Methods 0.000 description 2
• 238000011532 immunohistochemical staining Methods 0.000 description 2
• 238000012744 immunostaining Methods 0.000 description 2
• 238000009169 immunotherapy Methods 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 238000011534 incubation Methods 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 230000010354 integration Effects 0.000 description 2
• 230000016507 interphase Effects 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 238000011835 investigation Methods 0.000 description 2
• 238000002690 local anesthesia Methods 0.000 description 2
• 239000003589 local anesthetic agent Substances 0.000 description 2
• 239000011777 magnesium Substances 0.000 description 2
• 229910052749 magnesium Inorganic materials 0.000 description 2
• 238000002826 magnetic-activated cell sorting Methods 0.000 description 2
• 238000012423 maintenance Methods 0.000 description 2
• 201000009020 malignant peripheral nerve sheath tumor Diseases 0.000 description 2
• 210000002752 melanocyte Anatomy 0.000 description 2
• 210000003716 mesoderm Anatomy 0.000 description 2
• 238000001531 micro-dissection Methods 0.000 description 2
• 239000011325 microbead Substances 0.000 description 2
• 238000001000 micrograph Methods 0.000 description 2
• 230000011278 mitosis Effects 0.000 description 2
• 210000005087 mononuclear cell Anatomy 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 210000000933 neural crest Anatomy 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 230000037434 nonsense mutation Effects 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• 210000002488 outer root sheath cell Anatomy 0.000 description 2
• 230000002018 overexpression Effects 0.000 description 2
• 230000036407 pain Effects 0.000 description 2
• 206010033675 panniculitis Diseases 0.000 description 2
• 239000013618 particulate matter Substances 0.000 description 2
• 239000013610 patient sample Substances 0.000 description 2
• 210000002379 periodontal ligament Anatomy 0.000 description 2
• 230000002688 persistence Effects 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 239000012071 phase Substances 0.000 description 2
• YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
• 102000020233 phosphotransferase Human genes 0.000 description 2
• 208000001095 pilomatrixoma Diseases 0.000 description 2
• HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 2
• 230000001817 pituitary effect Effects 0.000 description 2
• 210000001778 pluripotent stem cell Anatomy 0.000 description 2
• 231100000719 pollutant Toxicity 0.000 description 2
• 229920001610 polycaprolactone Polymers 0.000 description 2
• 239000004632 polycaprolactone Substances 0.000 description 2
• 239000004417 polycarbonate Substances 0.000 description 2
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
• 229920001296 polysiloxane Polymers 0.000 description 2
• 229920002451 polyvinyl alcohol Polymers 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000008929 regeneration Effects 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• 210000002374 sebum Anatomy 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 239000002356 single layer Substances 0.000 description 2
• 201000000849 skin cancer Diseases 0.000 description 2
• 230000035943 smell Effects 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 239000001509 sodium citrate Substances 0.000 description 2
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
• DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 238000001228 spectrum Methods 0.000 description 2
• 230000037351 starvation Effects 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 238000003756 stirring Methods 0.000 description 2
• 210000004304 subcutaneous tissue Anatomy 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 229960001796 sunitinib Drugs 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 210000002435 tendon Anatomy 0.000 description 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
• 210000003437 trachea Anatomy 0.000 description 2
• 239000012581 transferrin Substances 0.000 description 2
• 210000004981 tumor-associated macrophage Anatomy 0.000 description 2
• 210000003954 umbilical cord Anatomy 0.000 description 2
• 230000035899 viability Effects 0.000 description 2
• 239000001993 wax Substances 0.000 description 2
• XUHRVZXFBWDCFB-QRTDKPMLSA-N (3R)-4-[[(3S,6S,9S,12R,15S,18R,21R,24R,27R,28R)-12-(3-amino-3-oxopropyl)-6-[(2S)-butan-2-yl]-3-(2-carboxyethyl)-18-(hydroxymethyl)-28-methyl-9,15,21,24-tetrakis(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-3-[[(2R)-2-[[(3S)-3-hydroxydecanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoic acid Chemical compound CCCCCCC[C@H](O)CC(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC1=O)[C@@H](C)CC XUHRVZXFBWDCFB-QRTDKPMLSA-N 0.000 description 1
• KZKAYEGOIJEWQB-UHFFFAOYSA-N 1,3-dibromopropane;n,n,n',n'-tetramethylhexane-1,6-diamine Chemical compound BrCCCBr.CN(C)CCCCCCN(C)C KZKAYEGOIJEWQB-UHFFFAOYSA-N 0.000 description 1
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
• VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
• IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• 108020005065 3' Flanking Region Proteins 0.000 description 1
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
• XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• 108020005029 5' Flanking Region Proteins 0.000 description 1
• WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
• 101150030271 AXIN1 gene Proteins 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 108700012045 Axin Proteins 0.000 description 1
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
• 229920002749 Bacterial cellulose Polymers 0.000 description 1
• 240000002132 Beaucarnea recurvata Species 0.000 description 1
• 206010070918 Bone deformity Diseases 0.000 description 1
• 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 102100022002 CD59 glycoprotein Human genes 0.000 description 1
• 101710147325 Calcineurin B homologous protein 3 Proteins 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 102100023126 Cell surface glycoprotein MUC18 Human genes 0.000 description 1
• 101710181333 Chaperone protein dnaK1 Proteins 0.000 description 1
• 229920002101 Chitin Polymers 0.000 description 1
• 229920002567 Chondroitin Polymers 0.000 description 1
• 208000028698 Cognitive impairment Diseases 0.000 description 1
• 206010010071 Coma Diseases 0.000 description 1
• 208000034656 Contusions Diseases 0.000 description 1
• 241000195493 Cryptophyta Species 0.000 description 1
• 108010068192 Cyclin A Proteins 0.000 description 1
• 108010060385 Cyclin B1 Proteins 0.000 description 1
• 108010058546 Cyclin D1 Proteins 0.000 description 1
• 102100025191 Cyclin-A2 Human genes 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102100024351 Dedicator of cytokinesis protein 7 Human genes 0.000 description 1
• 206010012335 Dependence Diseases 0.000 description 1
• 206010048768 Dermatosis Diseases 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 101100030375 Dictyostelium discoideum pho2a gene Proteins 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 102100031780 Endonuclease Human genes 0.000 description 1
• 108010042407 Endonucleases Proteins 0.000 description 1
• 102000007594 Estrogen Receptor alpha Human genes 0.000 description 1
• 108010007005 Estrogen Receptor alpha Proteins 0.000 description 1
• 206010063560 Excessive granulation tissue Diseases 0.000 description 1
• 102000010111 Ezrin/radixin/moesin Human genes 0.000 description 1
• 108050001788 Ezrin/radixin/moesin Proteins 0.000 description 1
• 101150104043 FLCN gene Proteins 0.000 description 1
• 241000272186 Falco columbarius Species 0.000 description 1
• 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
• 108010009306 Forkhead Box Protein O1 Proteins 0.000 description 1
• 206010017533 Fungal infection Diseases 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 1
• 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 description 1
• 101000993347 Gallus gallus Ciliary neurotrophic factor Proteins 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 206010064571 Gene mutation Diseases 0.000 description 1
• 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
• 102400000321 Glucagon Human genes 0.000 description 1
• 108060003199 Glucagon Proteins 0.000 description 1
• 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 description 1
• 102000002254 Glycogen Synthase Kinase 3 Human genes 0.000 description 1
• 208000009329 Graft vs Host Disease Diseases 0.000 description 1
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 102100040352 Heat shock 70 kDa protein 1A Human genes 0.000 description 1
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
• 229920002971 Heparan sulfate Polymers 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
• 101000899390 Homo sapiens Bone morphogenetic protein 6 Proteins 0.000 description 1
• 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 1
• 101000777270 Homo sapiens Calcineurin B homologous protein 3 Proteins 0.000 description 1
• 101000623903 Homo sapiens Cell surface glycoprotein MUC18 Proteins 0.000 description 1
• 101001052952 Homo sapiens Dedicator of cytokinesis protein 7 Proteins 0.000 description 1
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
• 101000599573 Homo sapiens InaD-like protein Proteins 0.000 description 1
• 101100029888 Homo sapiens PKD1 gene Proteins 0.000 description 1
• 101000872514 Homo sapiens Probable E3 ubiquitin-protein ligase HERC1 Proteins 0.000 description 1
• 101000583175 Homo sapiens Prolactin-inducible protein Proteins 0.000 description 1
• 101000610551 Homo sapiens Prominin-1 Proteins 0.000 description 1
• 101000933252 Homo sapiens Protein BEX3 Proteins 0.000 description 1
• 101000954805 Homo sapiens Protein Wnt-3a Proteins 0.000 description 1
• 101000726113 Homo sapiens Protein crumbs homolog 3 Proteins 0.000 description 1
• 101000611643 Homo sapiens Protein phosphatase 1 regulatory subunit 15A Proteins 0.000 description 1
• 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
• 101001123846 Homo sapiens Serine/threonine-protein kinase Nek1 Proteins 0.000 description 1
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
• 101100480755 Homo sapiens TBC1D7 gene Proteins 0.000 description 1
• 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 1
• 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 101100540311 Human papillomavirus type 16 E6 gene Proteins 0.000 description 1
• 102000018866 Hyaluronan Receptors Human genes 0.000 description 1
• 108010013214 Hyaluronan Receptors Proteins 0.000 description 1
• 108010003272 Hyaluronate lyase Proteins 0.000 description 1
• 102000001974 Hyaluronidases Human genes 0.000 description 1
• 102100037978 InaD-like protein Human genes 0.000 description 1
• 206010022971 Iron Deficiencies Diseases 0.000 description 1
• 108010025815 Kanamycin Kinase Proteins 0.000 description 1
• 102100025367 Keratin, type II cytoskeletal 75 Human genes 0.000 description 1
• 101710083590 Keratin, type II cytoskeletal 75 Proteins 0.000 description 1
• 108010066321 Keratin-14 Proteins 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• 229930182816 L-glutamine Natural products 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 102000016267 Leptin Human genes 0.000 description 1
• 108010092277 Leptin Proteins 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 229920001410 Microfiber Polymers 0.000 description 1
• ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
• 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 1
• 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 1
• 101001006254 Mus musculus Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial Proteins 0.000 description 1
• 102000008300 Mutant Proteins Human genes 0.000 description 1
• 108010021466 Mutant Proteins Proteins 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• 102000003729 Neprilysin Human genes 0.000 description 1
• 108090000028 Neprilysin Proteins 0.000 description 1
• 101150083321 Nf1 gene Proteins 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 108020003217 Nuclear RNA Proteins 0.000 description 1
• 102000043141 Nuclear RNA Human genes 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 1
• 208000012868 Overgrowth Diseases 0.000 description 1
• 239000007990 PIPES buffer Substances 0.000 description 1
• 101150056230 PKD1 gene Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 239000002033 PVDF binder Substances 0.000 description 1
• 206010033733 Papule Diseases 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 208000006735 Periostitis Diseases 0.000 description 1
• 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 229920000954 Polyglycolide Polymers 0.000 description 1
• 208000037062 Polyps Diseases 0.000 description 1
• 208000005214 Poroma Diseases 0.000 description 1
• 206010049422 Precancerous skin lesion Diseases 0.000 description 1
• 238000012274 Preoperative evaluation Methods 0.000 description 1
• 102100034747 Probable E3 ubiquitin-protein ligase HERC1 Human genes 0.000 description 1
• 206010036790 Productive cough Diseases 0.000 description 1
• WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 1
• 102100030350 Prolactin-inducible protein Human genes 0.000 description 1
• 102100040120 Prominin-1 Human genes 0.000 description 1
• 102100025955 Protein BEX3 Human genes 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102100027316 Protein crumbs homolog 3 Human genes 0.000 description 1
• 102100040714 Protein phosphatase 1 regulatory subunit 15A Human genes 0.000 description 1
• 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 1
• 101710189963 RB1-inducible coiled-coil protein 1 Proteins 0.000 description 1
• 102100023588 RB1-inducible coiled-coil protein 1 Human genes 0.000 description 1
• 238000011529 RT qPCR Methods 0.000 description 1
• 102000003901 Ras GTPase-activating proteins Human genes 0.000 description 1
• 108090000231 Ras GTPase-activating proteins Proteins 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 206010038997 Retroviral infections Diseases 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 108010034782 Ribosomal Protein S6 Kinases Proteins 0.000 description 1
• 102000009738 Ribosomal Protein S6 Kinases Human genes 0.000 description 1
• 102100039270 Ribulose-phosphate 3-epimerase Human genes 0.000 description 1
• 208000008620 Ruvalcaba syndrome Diseases 0.000 description 1
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
• 108091081021 Sense strand Proteins 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
• 102100028751 Serine/threonine-protein kinase Nek1 Human genes 0.000 description 1
• 102100038081 Signal transducer CD24 Human genes 0.000 description 1
• 108091027568 Single-stranded nucleotide Proteins 0.000 description 1
• 206010072170 Skin wound Diseases 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 206010042658 Sweat gland tumour Diseases 0.000 description 1
• 102100040254 TBC1 domain family member 7 Human genes 0.000 description 1
• 102100024547 Tensin-1 Human genes 0.000 description 1
• 108010088950 Tensins Proteins 0.000 description 1
• 108020005038 Terminator Codon Proteins 0.000 description 1
• AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 1
• 206010054094 Tumour necrosis Diseases 0.000 description 1
• 206010050283 Tumour ulceration Diseases 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• 206010047642 Vitiligo Diseases 0.000 description 1
• 210000002593 Y chromosome Anatomy 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
• 101710185494 Zinc finger protein Proteins 0.000 description 1
• 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
• 239000002250 absorbent Substances 0.000 description 1
• 230000002745 absorbent Effects 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 230000003044 adaptive effect Effects 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 238000004220 aggregation Methods 0.000 description 1
• 238000013019 agitation Methods 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 238000011166 aliquoting Methods 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 150000001413 amino acids Chemical class 0.000 description 1
• 210000004381 amniotic fluid Anatomy 0.000 description 1
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 230000003444 anaesthetic effect Effects 0.000 description 1
• 229940035676 analgesics Drugs 0.000 description 1
• 201000002996 androgenic alopecia Diseases 0.000 description 1
• 229940035674 anesthetics Drugs 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 239000000730 antalgic agent Substances 0.000 description 1
• 230000000843 anti-fungal effect Effects 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000003443 antiviral agent Substances 0.000 description 1
• 201000005130 apocrine adenoma Diseases 0.000 description 1
• 239000012122 aqueous mounting media Substances 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 239000005016 bacterial cellulose Substances 0.000 description 1
• 239000003855 balanced salt solution Substances 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 210000000270 basal cell Anatomy 0.000 description 1
• 239000007640 basal medium Substances 0.000 description 1
• 208000030756 basaloid follicular hamartoma Diseases 0.000 description 1
• 230000003542 behavioural effect Effects 0.000 description 1
• 206010004398 benign neoplasm of skin Diseases 0.000 description 1
• PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 238000001574 biopsy Methods 0.000 description 1
• 210000003969 blast cell Anatomy 0.000 description 1
• 229930189065 blasticidin Natural products 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 230000036770 blood supply Effects 0.000 description 1
• 238000009835 boiling Methods 0.000 description 1
• 230000008468 bone growth Effects 0.000 description 1
• 108010006025 bovine growth hormone Proteins 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 1
• 229960001736 buprenorphine Drugs 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 230000002612 cardiopulmonary effect Effects 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 210000000845 cartilage Anatomy 0.000 description 1
• 150000001767 cationic compounds Chemical class 0.000 description 1
• 229960001139 cefazolin Drugs 0.000 description 1
• MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
• 230000034303 cell budding Effects 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000005779 cell damage Effects 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 208000037887 cell injury Diseases 0.000 description 1
• 238000001516 cell proliferation assay Methods 0.000 description 1
• 238000002737 cell proliferation kit Methods 0.000 description 1
• 230000003833 cell viability Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 230000002490 cerebral effect Effects 0.000 description 1
• 238000002038 chemiluminescence detection Methods 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 230000035606 childbirth Effects 0.000 description 1
• DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
• 208000020832 chronic kidney disease Diseases 0.000 description 1
• 238000000975 co-precipitation Methods 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 239000000512 collagen gel Substances 0.000 description 1
• 239000000515 collagen sponge Substances 0.000 description 1
• 230000009918 complex formation Effects 0.000 description 1
• 230000003750 conditioning effect Effects 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 238000007596 consolidation process Methods 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 239000002537 cosmetic Substances 0.000 description 1
• 239000006059 cover glass Substances 0.000 description 1
• 238000005138 cryopreservation Methods 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 230000001351 cycling effect Effects 0.000 description 1
• 230000002380 cytological effect Effects 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000018044 dehydration Effects 0.000 description 1
• 238000006297 dehydration reaction Methods 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 239000005549 deoxyribonucleoside Substances 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 238000002224 dissection Methods 0.000 description 1
• 238000002651 drug therapy Methods 0.000 description 1
• 238000004043 dyeing Methods 0.000 description 1
• 230000002900 effect on cell Effects 0.000 description 1
• 230000013020 embryo development Effects 0.000 description 1
• 210000001671 embryonic stem cell Anatomy 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 208000028208 end stage renal disease Diseases 0.000 description 1
• 201000000523 end stage renal failure Diseases 0.000 description 1
• 210000003038 endothelium Anatomy 0.000 description 1
• 210000003989 endothelium vascular Anatomy 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 238000009585 enzyme analysis Methods 0.000 description 1
• 230000002327 eosinophilic effect Effects 0.000 description 1
• 201000005616 epidermal appendage tumor Diseases 0.000 description 1
• 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
• 239000006167 equilibration buffer Substances 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 229960005309 estradiol Drugs 0.000 description 1
• 229930182833 estradiol Natural products 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 230000005713 exacerbation Effects 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 210000003020 exocrine pancreas Anatomy 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 239000011536 extraction buffer Substances 0.000 description 1
• 210000003195 fascia Anatomy 0.000 description 1
• 239000012894 fetal calf serum Substances 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 229940126864 fibroblast growth factor Drugs 0.000 description 1
• 102000034240 fibrous proteins Human genes 0.000 description 1
• 108091005899 fibrous proteins Proteins 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 229960004039 finasteride Drugs 0.000 description 1
• DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
• 235000019688 fish Nutrition 0.000 description 1
• 238000000799 fluorescence microscopy Methods 0.000 description 1
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
• 231100000221 frame shift mutation induction Toxicity 0.000 description 1
• 230000037433 frameshift Effects 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 239000003193 general anesthetic agent Substances 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 210000004602 germ cell Anatomy 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
• 229960004666 glucagon Drugs 0.000 description 1
• 150000004676 glycans Polymers 0.000 description 1
• 208000024908 graft versus host disease Diseases 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 210000001126 granulation tissue Anatomy 0.000 description 1
• 230000003660 hair regeneration Effects 0.000 description 1
• 238000012835 hanging drop method Methods 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 230000023597 hemostasis Effects 0.000 description 1
• 229950007870 hexadimethrine bromide Drugs 0.000 description 1
• 208000002557 hidradenitis Diseases 0.000 description 1
• 230000036732 histological change Effects 0.000 description 1
• 238000000265 homogenisation Methods 0.000 description 1
• 230000006801 homologous recombination Effects 0.000 description 1
• 238000002744 homologous recombination Methods 0.000 description 1
• 102000056781 human WNT3A Human genes 0.000 description 1
• 102000054584 human Y acceptor Human genes 0.000 description 1
• 108700023876 human Y acceptor Proteins 0.000 description 1
• 229960002773 hyaluronidase Drugs 0.000 description 1
• 208000003532 hypothyroidism Diseases 0.000 description 1
• 230000002989 hypothyroidism Effects 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 238000003365 immunocytochemistry Methods 0.000 description 1
• 238000010820 immunofluorescence microscopy Methods 0.000 description 1
• 239000012133 immunoprecipitate Substances 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000000126 in silico method Methods 0.000 description 1
• 239000012073 inactive phase Substances 0.000 description 1
• 238000007373 indentation Methods 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 210000004969 inflammatory cell Anatomy 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 229910001411 inorganic cation Inorganic materials 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 239000007928 intraperitoneal injection Substances 0.000 description 1
• 230000001788 irregular Effects 0.000 description 1
• 201000007785 kidney angiomyolipoma Diseases 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• 210000001821 langerhans cell Anatomy 0.000 description 1
• 238000000608 laser ablation Methods 0.000 description 1
• 238000001001 laser micro-dissection Methods 0.000 description 1
• 229940039781 leptin Drugs 0.000 description 1
• NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 238000001638 lipofection Methods 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 238000000464 low-speed centrifugation Methods 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 210000001365 lymphatic vessel Anatomy 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 239000006249 magnetic particle Substances 0.000 description 1
• 238000007885 magnetic separation Methods 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 210000001161 mammalian embryo Anatomy 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• 210000000135 megakaryocyte-erythroid progenitor cell Anatomy 0.000 description 1
• 210000000716 merkel cell Anatomy 0.000 description 1
• 210000005033 mesothelial cell Anatomy 0.000 description 1
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
• 239000003658 microfiber Substances 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 238000003801 milling Methods 0.000 description 1
• 229960003632 minoxidil Drugs 0.000 description 1
• 230000000394 mitotic effect Effects 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000000877 morphologic effect Effects 0.000 description 1
• 210000002200 mouth mucosa Anatomy 0.000 description 1
• 210000000651 myofibroblast Anatomy 0.000 description 1
• 229920005615 natural polymer Polymers 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 108010090677 neurofilament protein L Proteins 0.000 description 1
• 210000004498 neuroglial cell Anatomy 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 210000002445 nipple Anatomy 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 230000006780 non-homologous end joining Effects 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 230000005305 organ development Effects 0.000 description 1
• 210000003463 organelle Anatomy 0.000 description 1
• 208000023112 overgrowth syndrome Diseases 0.000 description 1
• 239000003973 paint Substances 0.000 description 1
• 201000010148 papillary adenoma Diseases 0.000 description 1
• 208000014960 papillary eccrine carcinoma Diseases 0.000 description 1
• 230000003076 paracrine Effects 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 230000000149 penetrating effect Effects 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 210000003460 periosteum Anatomy 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 210000000578 peripheral nerve Anatomy 0.000 description 1
• 102000013415 peroxidase activity proteins Human genes 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 229960005095 pioglitazone Drugs 0.000 description 1
• 239000008104 plant cellulose Substances 0.000 description 1
• 108010056274 polo-like kinase 1 Proteins 0.000 description 1
• 229920000747 poly(lactic acid) Polymers 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 229920001707 polybutylene terephthalate Polymers 0.000 description 1
• 229920000515 polycarbonate Polymers 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 239000004633 polyglycolic acid Substances 0.000 description 1
• 239000004626 polylactic acid Substances 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 102000054765 polymorphisms of proteins Human genes 0.000 description 1
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
• 208000015768 polyposis Diseases 0.000 description 1
• 150000004804 polysaccharides Polymers 0.000 description 1
• 229920000053 polysorbate 80 Polymers 0.000 description 1
• 229920002635 polyurethane Polymers 0.000 description 1
• 239000004814 polyurethane Substances 0.000 description 1
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• 238000003793 prenatal diagnosis Methods 0.000 description 1
• 230000001023 pro-angiogenic effect Effects 0.000 description 1
• 239000000186 progesterone Substances 0.000 description 1
• 229960003387 progesterone Drugs 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 238000000751 protein extraction Methods 0.000 description 1
• 239000012460 protein solution Substances 0.000 description 1
• LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 238000001959 radiotherapy Methods 0.000 description 1
• 238000003753 real-time PCR Methods 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 230000037309 reepithelialization Effects 0.000 description 1
• 230000001172 regenerating effect Effects 0.000 description 1
• 230000001373 regressive effect Effects 0.000 description 1
• 230000026267 regulation of growth Effects 0.000 description 1
• 238000002271 resection Methods 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 230000002207 retinal effect Effects 0.000 description 1
• 230000001177 retroviral effect Effects 0.000 description 1
• 239000002342 ribonucleoside Substances 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 229960004586 rosiglitazone Drugs 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 201000005218 sebaceous adenoma Diseases 0.000 description 1
• 230000033785 sebaceous gland development Effects 0.000 description 1
• 201000010383 sebaceous gland neoplasm Diseases 0.000 description 1
• 229940000207 selenious acid Drugs 0.000 description 1
• 229910052711 selenium Inorganic materials 0.000 description 1
• 239000011669 selenium Substances 0.000 description 1
• MCAHWIHFGHIESP-UHFFFAOYSA-N selenous acid Chemical compound O[Se](O)=O MCAHWIHFGHIESP-UHFFFAOYSA-N 0.000 description 1
• 210000000697 sensory organ Anatomy 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 238000004088 simulation Methods 0.000 description 1
• 230000037075 skin appearance Effects 0.000 description 1
• 208000017520 skin disease Diseases 0.000 description 1
• 210000001626 skin fibroblast Anatomy 0.000 description 1
• 230000037067 skin hydration Effects 0.000 description 1
• 206010040872 skin infection Diseases 0.000 description 1
• 238000003307 slaughter Methods 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 210000004894 snout Anatomy 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 229940005550 sodium alginate Drugs 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 229940054269 sodium pyruvate Drugs 0.000 description 1
• XOIQMTLWECTKJL-HXPDMXKUSA-M sodium;(3r,4s)-4-[(2s,5r,7s,8r,9s)-2-[(2r,5s)-5-ethyl-5-[(2r,3s,5r)-5-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate Chemical compound [Na+].C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)C(C)C([O-])=O)O2 XOIQMTLWECTKJL-HXPDMXKUSA-M 0.000 description 1
• 238000000935 solvent evaporation Methods 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 230000037436 splice-site mutation Effects 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 210000003802 sputum Anatomy 0.000 description 1
• 208000024794 sputum Diseases 0.000 description 1
• 208000017572 squamous cell neoplasm Diseases 0.000 description 1
• 238000003153 stable transfection Methods 0.000 description 1
• 238000007447 staining method Methods 0.000 description 1
• 206010048905 steatocystoma multiplex Diseases 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 238000013517 stratification Methods 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 210000004003 subcutaneous fat Anatomy 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 239000002344 surface layer Substances 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 229920002994 synthetic fiber Polymers 0.000 description 1
• 229920001059 synthetic polymer Polymers 0.000 description 1
• 208000030508 syringofibroadenoma Diseases 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 210000004876 tela submucosa Anatomy 0.000 description 1
• KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
• 229960003604 testosterone Drugs 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 238000005382 thermal cycling Methods 0.000 description 1
• 230000003813 thin hair Effects 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 229940113082 thymine Drugs 0.000 description 1
• 230000008467 tissue growth Effects 0.000 description 1
• 239000012859 tissue stain Substances 0.000 description 1
• 239000010936 titanium Substances 0.000 description 1
• 229910052719 titanium Inorganic materials 0.000 description 1
• 238000004448 titration Methods 0.000 description 1
• 229950003937 tolonium Drugs 0.000 description 1
• HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 230000002463 transducing effect Effects 0.000 description 1
• 238000003146 transient transfection Methods 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 208000000654 trichofolliculoma Diseases 0.000 description 1
• 229940035722 triiodothyronine Drugs 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 210000005239 tubule Anatomy 0.000 description 1
• 230000036269 ulceration Effects 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 210000003934 vacuole Anatomy 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 238000003260 vortexing Methods 0.000 description 1